|
US6303321B1
(en)
|
1999-02-11 |
2001-10-16 |
North Shore-Long Island Jewish Research Institute |
Methods for diagnosing sepsis
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
US7696169B2
(en)
|
2003-06-06 |
2010-04-13 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
WO2005025604A2
(en)
*
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
AU2004272607B2
(en)
|
2003-09-11 |
2008-11-06 |
Cornerstone Therapeutics Inc. |
Monoclonal antibodies against HMGB1
|
|
PT1768677E
(pt)
*
|
2004-07-02 |
2008-10-06 |
Creabilis Therapeutics Spa |
Ácidos nucleicos para o tratamento de patologias relacionadas com hmgb1
|
|
WO2006012373A2
(en)
*
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Combination therapies of hmgb and complement inhibitors against inflammation
|
|
CA2579094C
(en)
*
|
2004-09-03 |
2014-12-02 |
Creabilis Therapeutics S.P.A. |
Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1
|
|
JP2008520552A
(ja)
*
|
2004-10-22 |
2008-06-19 |
メディミューン,インコーポレーテッド |
Hmgb1に対する高親和性の抗体およびその使用法
|
|
WO2006138429A2
(en)
*
|
2005-06-16 |
2006-12-28 |
The Feinstein Institute For Medical Research |
Antibodies against hmgb1 and fragments thereof
|
|
WO2007011606A2
(en)
*
|
2005-07-18 |
2007-01-25 |
Critical Therapeutics, Inc. |
USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
|
|
WO2007031100A1
(en)
*
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
|
WO2007054090A1
(en)
*
|
2005-11-09 |
2007-05-18 |
Pharmexa A/S |
Therapeutic vaccines targeting hmgb1
|
|
JP2010503630A
(ja)
*
|
2006-09-15 |
2010-02-04 |
クレアビリス・セラピューティクス・エスピーエー |
HMGB1のBox−AおよびHMGB1のBox−A変異体のポリマー複合体
|
|
EP2517723B1
(en)
|
2006-09-18 |
2019-11-06 |
The Board of Trustees of The University of Arkansas |
Compositions and methods of enhancing immune responses
|
|
US8470325B2
(en)
|
2007-02-15 |
2013-06-25 |
Kagoshima University |
Method of treating amykloidosis comprising administering an anti-HMGB-1 antibody
|
|
WO2009133943A1
(ja)
|
2008-04-30 |
2009-11-05 |
株式会社ジェノミックス |
生体内機能的細胞の高効率採取法
|
|
KR20120135190A
(ko)
|
2009-10-28 |
2012-12-12 |
고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 |
골수 간엽계 및/또는 다능성 줄기세포의 혈중 동원(動員)에 의한 조직 재생 촉진제
|
|
CN102811734B
(zh)
|
2010-01-21 |
2016-02-10 |
阿肯色大学评议会 |
增强免疫应答的疫苗载体和方法
|
|
CA2800830C
(en)
|
2010-06-09 |
2020-09-08 |
The Board Of Trustees Of The University Of Arkansas |
Vaccine and methods to reduce campylobacter infection
|
|
EP3358011B1
(en)
|
2011-04-26 |
2020-03-04 |
StemRIM Inc. |
Peptide for inducing regeneration of tissue and use thereof
|
|
JP6253589B2
(ja)
|
2012-10-25 |
2017-12-27 |
株式会社ジェノミックス |
Hmgb1断片を利用した新規心筋梗塞の治療法
|
|
DK2913059T3
(en)
*
|
2012-10-25 |
2018-06-25 |
Genomix Co Ltd |
Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT
|
|
MX2015009547A
(es)
|
2013-01-28 |
2015-11-25 |
Evec Inc |
Anticuerpo anti-hmgb1 humanizado o fragmento de union al antigeno del mismo.
|
|
HUE047484T2
(hu)
|
2013-02-14 |
2020-04-28 |
Univ Arkansas |
Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
|
|
US10376571B2
(en)
|
2013-03-15 |
2019-08-13 |
The Board Of Trustees Of The University Of Arkansas |
Compositions and methods of enhancing immune responses to enteric pathogens
|
|
KR20190015712A
(ko)
|
2016-05-03 |
2019-02-14 |
더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 |
면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
|
|
AU2018213671B2
(en)
|
2017-01-27 |
2024-06-06 |
Osaka University |
Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure
|
|
EP3595445B1
(en)
|
2017-03-15 |
2024-09-04 |
The Research Institute at Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
|
AU2018376452A1
(en)
|
2017-12-01 |
2020-06-25 |
Osaka University |
Ectodermal mesenchymal stem cells and method for producing same
|
|
EP3718561A4
(en)
|
2017-12-01 |
2021-07-21 |
Stemrim Inc. |
Therapy for inflammatory bowel disease
|
|
US20210024594A1
(en)
|
2018-02-08 |
2021-01-28 |
StemRIM Inc. |
Therapeutic Agent for Psoriasis
|
|
US12304933B2
(en)
|
2018-10-05 |
2025-05-20 |
StemRIM Inc. |
Disease treatment drug based on mesenchymal-stem-cell mobilization
|
|
JP2022504139A
(ja)
|
2018-10-05 |
2022-01-13 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
バイオフィルムの除去のためのhmgb1タンパク質誘導体
|
|
CN111743890A
(zh)
*
|
2019-03-26 |
2020-10-09 |
深圳先进技术研究院 |
水绫霉素或其衍生物的用途
|